Pfizer Acquires Biotech Firm Specializing In Cancer Treatments For $43 Billion

Pfizer Acquires Biotech Firm Specializing In Cancer Treatments For $43 Billion


Pharmaceutical giant Pfizer expanded its profile on Monday to access cancer treatments.

Why would the COVID-19 jab manufacturer need to specialize in cancer treatments?

Perhaps it’s another case of Big Pharma providing the ‘cure’ for the illness they created?

Trending: SHE WILL LEAVE YOU SPEECHLESS! Michigan’s New GOP Chair Kristina Karamo Gives Brilliant History Lesson to Leftist Media Activists on Gun Control in EPIC Press Conference [VIDEO]

WATCH: Dr. Ryan Cole Reports 20X Increase of Cancers & Autoimmune Diseases in Vaccinated Patients

Pfizer announced that it acquired Seagen, a biotech firm that specializes in innovative cancer treatments, for $43 billion.

The Pharma giant said it would pay $229 a share in cash.

“We are not buying the golden eggs,” Pfizer CEO Albert Bourla reportedly said.

“We are acquiring the goose that is laying the golden eggs.”

NEW – Pfizer announced Monday that it had reached a deal to buy biotech firm

Continue reading


 

Join the conversation!

Please share your thoughts about this article below. We value your opinions, and would love to see you add to the discussion!

Daily Truth Report • DailyTruthReport.com
Thanks for sharing!
Send this to a friend